Replies to post #171839 on Biotech Values

[zipjet]

GENT / JAZZ

It is very clear from reading the 14D9 that Sigma Tau is not supportive of the deal at $57. Their representative on the BOD of GENT abstained from all the necessary votes.

ST has 17.4% of the stock.

Ball is in their court.

And GENT stock continues to trade above the JAZZ offer price.

I see no reason to tender GENT shares until there is no choice.

[zipjet]

GENT / JAZZ per ghmm

On November 11, 2013, Dr. Islam provided an update to the members of the Company Board on the status of the Company's solicitation process and the meetings held in Vienna, and indicated that the Company's discussions with Parent, as well as Parent's due diligence review, were at a relatively advanced stage. Of the 13 companies that met with management at BIO-Europe, three of them (Company C, Company D and Company E) expressed interest in conducting more detailed due diligence on the Company and executed confidentiality agreements with the Company between November 11, 2013 and November 13, 2013. Seven other companies did not request access to more detailed due diligence on the Company, but continued a dialogue with Jefferies regarding their potential interest in the Company over the next several weeks. After consulting with the Company's advisors, the Company entered into a customary form of confidentiality agreement, which included a one-year standstill provision, with each of Company C, Company D and Company E. All of these standstill provisions terminated by their terms as a result of the execution of the tender offer agreement between the Company and Parent and, as of the date hereof, no longer have force or effect.